We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Algorithm Detects 30% Of Breast Cancers Missed on MRI Scans

By HospiMedica International staff writers
Posted on 07 Nov 2024

In the United States, more than 500,000 women participate in supplemental breast magnetic resonance imaging (MRI) screenings each year. More...

These women are considered to be at an elevated risk for breast cancer. Following a negative screening mammogram, supplemental MRI can uncover an additional 15 to 18 cancers per 1,000 high-risk women. Thanks to the higher sensitivity of MRI compared to mammography, it may be feasible to estimate an individual's risk of developing cancer within the upcoming year based on their most recent negative screening MRI. Researchers have proposed that current MRI examinations contain valuable information regarding the outcome of the next annual screening. Based on this hypothesis, they have developed and assessed an artificial intelligence (AI) algorithm to identify breast cancer in MRI scans up to one year earlier than when radiologists typically detect it, potentially improving early detection among high-risk women.

A research team from The City College of New York (New York, NY, USA) fine-tuned a convolutional neural network (CNN) AI model, which was pre-trained on breast MRI data, utilizing a retrospective dataset that included 3,029 MRI scans from 910 patients. This dataset contained 115 cancers diagnosed within a year of a negative MRI result. The model aimed to identify these cancers to predict the development of cancer as much as one year in advance. The network was fine-tuned and validated using a 10-fold cross-validation method. The mean age of the patients involved was 52 years, ranging from 18 to 88 years, with an average follow-up duration of 4.3 years, spanning from 1 to 12 years.

The AI was able to detect cancers a year earlier, achieving an area under the ROC curve of 0.72. A retrospective review by a radiologist of the top 10% highest risk MRIs, as ranked by the AI, could have boosted early detection by up to 30%. The radiologist identified a visual marker for biopsy-proven cancers in 83 MRI scans from the previous year. The AI algorithm pinpointed the anatomical regions where cancer would be detected in 66 cases, with agreement between the two methods in 54 instances. Based on the findings published in Academic Radiology, the researchers concluded that their innovative AI-assisted re-evaluation of "benign" breast scans holds promise for enhancing early breast cancer detection through MRI. As datasets expand and image quality continues to improve, they anticipate that this method will become increasingly influential.


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.